Abstract
Stroke is one of the leading causes of morbidity and permanent disability worldwide. There is a need for an efficacious alternative therapy administered beyond the limitation of time window based on the biological characteristics of stroke, currently. The immunomodulatory therapy could extend the time window while not increase the risk of hemorrhage which made it become candidate treatments. In this paper, we integrated several gene expression profiles generated from the peripheral blood of ischemic stroke patients and health people. Differential expressed cytokines were first selected as candidate cytokines. Enrichment analyses were then performed to filter the candidate cytokines as biomarkers (E-CKs) by checking the relationships between them and the stroke related functional terms. More cytokines were found as biomarkers in the sub-acute stage of ischemic stroke compared with acute and chronic stages which could be explained by the great changes in microenvironment in this necrosis stage. Analyses based on microRNomics level showed that more E-CKs one miRNA regulated, the more important role it played in stroke related processes. Similarly, analyses on proteomics level showed that E-CKs with top degrees in the protein-protein interaction network were proved to be closely related to stroke. Most E-CKs participate in both the stroke processing and rehabilitation, thus, the dual immune characters made them become valuable potential targets of immunomodulatory therapies.
Y. Wang and J. Liu contributed equally to this paper.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jiang, Y., Zhu, W., Zhu, J., et al.: Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. Cell Transplant. 22(12), 2291–2298 (2013)
Lees, K.R., Bluhmki, E., von Kummer, R., et al.: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375(9727), 1695–1703 (2010)
Fonarow, G.C., Smith, E.E., Saver, J.L., et al.: Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 123(7), 750–758 (2011)
Lo, E.H.: Degeneration and repair in central nervous system disease. Nat. Med. 16, 1205–1209 (2010)
Morancho, A., Rosell, A., Garcia-Bonilla, L., et al.: Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann. N. Y. Acad. Sci. 1207, 123–133 (2010)
Xu, X., Jiang, Y.: The Yin and Yang of innate immunity in stroke. Biomed. Res. Int. 2014, 807978 (2014)
Shichita, T., Ago, T., Kamouchi, M., et al.: Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J. Neurochem. 123(supplement 2), 29–38 (2012)
Banwell, V., Sena, E.S., Macleod, M.R.: Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J. Stroke Cerebrovasc. Dis. 18(4), 269–276 (2009)
Gertz, K., Kronenberg, G., Kälin, R.E., et al.: Essential role of interleukin-6 in post-stroke angiogenesis. Brain J. Neurol. 135(6), 1964–1980 (2012)
Zeng, L., Wang, Y., Liu, J., et al.: Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neurosci. Lett. 548, 4–9 (2013)
Cure, M.C., Tufekci, A., Cure, E., et al.: Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke. Ann. Indian Acad. Neurol. 16(4), 498–503 (2013)
Maddahi, A., Kruse, L.S., Chen, Q.W., et al.: The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat. J. Neuroinflammation 8, 107 (2011)
Yingying, W., Yunpeng, C.: A survey on database resources for microRNA-disease relationships. Brief Funct. Genomics 16(3), 146–151 (2017)
Yingying, W., Yunpeng, C.: Obtaining human ischemic stroke gene expression biomarkers from animal models: a cross-species validation study. Sci Rep. 6, 29693 (2016)
Jing, L., Yunpeng, Z., Yingying, W., et al.: Functional combination strategy for prioritization of human miRNA target. Gene 533(1), 132–141 (2014)
Yingying, W., Lei, D., Xia, L., et al.: Functional homogeneity in microRNA target heterogeneity - a new sight into human microRNomics. OMICS J. Integr. Biol. 15(1-2), 25–35 (2011)
Yingying, W., Yunpeng, C.: A network-based analysis of ischemic stroke using parallel microRNA-mRNA expression profiles. In: GlobalSIP14-Workshop on Genomic Signal Processing and Statistics. Atlanta, Georgia, USA, 03–05 December 2014
Barrett, T., Wilhite, S.E., Ledoux, P., et al.: NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 41, D991–D995 (2013)
Stamova, B., Jickling, G.C., Ander, B.P., et al.: Gene expression in peripheral immune cells following cardioembolic stroke is sexually dimorphic. PLoS ONE 9, e102550 (2014)
Barr, T.L., VanGilder, R., Rellick, S., et al.: A genomic profile of the immune response to stroke with implications for stroke recovery. Biol. Res. Nurs. 17, 248–256 (2015)
Krug, T., Gabriel, J.P., Taipa, R., et al.: TTC7B emerges as a novel risk factor for ischemic stroke through the convergence of several genome-wide approaches. J. Cereb. Blood Flow Metab. 32, 1061–1072 (2012)
Fagan, S.C., Hess, D.C., Hohnadel, E.J., et al.: Targets for vascular protection after acute ischemic stroke. Stroke 35(9), 2220–2225 (2004)
Subramanian, A., Tamayo, P., Mootha, V.K., et al.: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102(43), 15545–15550 (2005)
Keshava Prasad, T.S., Goel, R., Kandasamy, K., et al.: Human protein reference database–2009 update. Nucleic Acids Res. 37, D767–D772 (2009)
Chou, C.H., Chang, N.W., Shrestha, S., et al.: miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 44, D239–D247 (2016)
Liu, F.J., Kaur, P., Karolina, D.S., et al.: MiR-335 Regulates Hif-1α to reduce cell death in both mouse cell line and rat ischemic models. PLoS ONE 10(6), e0128432 (2015)
Zhang, H., Liu, L., Hu, J., et al.: MicroRNA regulatory network revealing the mechanism of inflammation in atrial fibrillation. Med. Sci. Monit. 14(21), 3505–3513 (2015)
Rainer, T.H., Leung, L.Y., Chan, C.P., et al.: Plasma miR-124-3p and miR-16 concentrations as prognostic markers in acute stroke. Clin. Biochem. 49(9), 663–668 (2016)
Wen, Y., Zhang, X., Dong, L., et al.: Acetylbritannilactone modulates MicroRNA-155-Mediated inflammatory response in ischemic cerebral tissues. Mol. Med. 18(21), 197–209 (2015)
Wang, Y., Dong, X., Li, Z., et al.: Downregulated RASD1 and upregulated miR-375 are involved in protective effects of calycosin on cerebral ischemia/reperfusion rats. J. Neurol. Sci. 339(1–2), 144–148 (2014)
Liu, X.L., Du, J.Z., Zhou, Y.M., et al.: Interleukin-16 polymorphism is associated with an increased risk of ischemic stroke. Mediators Inflamm. 2013, Article ID 564750 (2013)
Mostafa, M.A., El-Nabiel, L.M., Fahmy, N.A., et al.: ACE gene in Egyptian ischemic stroke patients. J. Stroke Cerebrovasc. Dis. 25(9), 2167–2171 (2016)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this paper
Cite this paper
Wang, Y., Liu, J., Yu, H., Cai, Y. (2017). Analyses of the Dual Immune Roles Cytokines Play in Ischemic Stroke. In: Siuly, S., et al. Health Information Science. HIS 2017. Lecture Notes in Computer Science(), vol 10594. Springer, Cham. https://doi.org/10.1007/978-3-319-69182-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-69182-4_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69181-7
Online ISBN: 978-3-319-69182-4
eBook Packages: Computer ScienceComputer Science (R0)